As food and oil prices rocket all over the world, consumers are getting a crash course in economics: When demand increases, prices increase. Although food and oil dominate the headlines, life’s other essentials also obey this cast-iron law, including healthcare, which is threatening to bust government budgets all over the world. As with food, part of the solution lies in opening up trade and competition.
The Organization of Economic Community and Development estimates that world average healthcare expenditure last year accounted for 9 percent of GDP, up from just over 5 percent in 1970. The US now spends more than US$2 trillion per year on healthcare, eight times the amount in 1980. US healthcare costs are currently increasing by twice general inflation, a general trend in rich countries.
As populations grow older and more demanding, these inflationary pressures will increase. Politicians are finding cashed-strapped voters increasingly unwilling to stump up the large amounts of tax needed to fund government health systems, forcing them to deny treatments to patients in a bid to constrain costs. In the US, healthcare costs have become a major issue in the presidential election.
The last decade, by contrast, has seen very low inflation for other goods, partly because of a massive increase in global trade. The arrival of China and India as major new exporters has meant that most countries have been able to import goods cheaply, keeping prices down.
While the role of free trade in driving down prices and driving up quality has long been accepted by economists (and, to an extent, politicians), healthcare has been one area in which there has been almost no international trade. It is time for this to change.
Communications technology makes it increasingly easy for hospitals to outsource services such as diagnostics to laboratories overseas, cutting costs and treatment time.
Patients can get treatment overseas where costs are lower. Open-heart surgery in India costs only one-sixth of the price in the US, including travel, accommodation and medicines. If only 10 percent of US patients went abroad for 15 types of treatment, they and insurance firms could save US$1.5 billion a year, including travel.
Patients are already voting with their feet. In 2006 alone, Singapore treated 500,000 foreign patients, India treated 600,000 and Thailand around 1.2 million. Other favorite destinations include Malaysia, South Africa and Cuba. Taiwan’s Council for Economic Planning and Development believes it could bring in NT$7 billion (US$230.4 million) a year.
While the benefits of free trade in health are clear for rich countries, developing countries also stand to gain. Most obviously, there are opportunities for much-needed investment of foreign capital.
These financial opportunities would also give developing countries’ medical staff a far greater incentive to remain at home, reducing the debilitating “brain drain.” As more money came into the health sector, some of the burden on government healthcare would be removed.
Despite the significant benefits, only two developed countries have ratified a WTO agreement on trade in healthcare — Iceland and Norway. While developing countries such as Gambia, Jamaica, Malawi and South Africa are prepared to liberalize, wealthier countries seem bent on protectionism.
This reluctance is largely down to lobbying by interest groups in developed countries. Public sector unions seek to protect their members and industries from competition. Non-governmental organizations ideologically oppose trade in healthcare, claiming that only governments can ensure “equity” and “universal” treatment — even though public healthcare in most of the world fails patients miserably.
This is a massive wasted opportunity. Free trade in healthcare could help rich countries keep the lid on healthcare inflation while helping poorer countries attract investment and skills and retain valuable medical professionals.
For this to happen, developed countries must encourage insurers to cover overseas treatment and open up their medical sectors to international competition. Developing countries need to standardize their qualification and licensing requirements in order to attract customers and improve skills.
Healthcare doesn’t have to go the same way as food prices. Rich and poor countries should ignore calls for protectionism and liberalize their healthcare for the good of patients everywhere. Health tourism can be healthy for everyone.
Fredrik Erixon is director and Lucy Davis a trade policy analyst of the Europe Centre for International Political Economy, a think tank based in Brussels.
A return to power for former US president Donald Trump would pose grave risks to Taiwan’s security, autonomy and the broader stability of the Indo-Pacific region. The stakes have never been higher as China aggressively escalates its pressure on Taiwan, deploying economic, military and psychological tactics aimed at subjugating the nation under Beijing’s control. The US has long acted as Taiwan’s foremost security partner, a bulwark against Chinese expansionism in the region. However, a second Trump presidency could upend decades of US commitments, introducing unpredictability that could embolden Beijing and severely compromise Taiwan’s position. While president, Trump’s foreign policy reflected a transactional
Chinese President Xi Jinping (習近平) has prioritized modernizing the Chinese People’s Liberation Army (PLA) to rival the US military, with many experts believing he would not act on Taiwan until the PLA is fully prepared to confront US forces. At the Chinese Communist Party’s 20th Party Congress in 2022, Xi emphasized accelerating this modernization, setting 2027 — the PLA’s centennial — as the new target, replacing the previous 2035 goal. US intelligence agencies said that Xi has directed the PLA to be ready for a potential invasion of Taiwan by 2027, although no decision on launching an attack had been made. Whether
A chip made by Taiwan Semiconductor Manufacturing Co (TSMC) was found on a Huawei Technologies Co artificial intelligence (AI) processor, indicating a possible breach of US export restrictions that have been in place since 2019 on sensitive tech to the Chinese firm and others. The incident has triggered significant concern in the IT industry, as it appears that proxy buyers are acting on behalf of restricted Chinese companies to bypass the US rules, which are intended to protect its national security. Canada-based research firm TechInsights conducted a die analysis of the Huawei Ascend 910B AI Trainer, releasing its findings on Oct.
In honor of President Jimmy Carter’s 100th birthday, my longtime friend and colleague John Tkacik wrote an excellent op-ed reassessing Carter’s derecognition of Taipei. But I would like to add my own thoughts on this often-misunderstood president. During Carter’s single term as president of the United States from 1977 to 1981, despite numerous foreign policy and domestic challenges, he is widely recognized for brokering the historic 1978 Camp David Accords that ended the state of war between Egypt and Israel after more than three decades of hostilities. It is considered one of the most significant diplomatic achievements of the 20th century.